Having a high body mass index reduces the risk for developing breast cancer before menopause, but more research is needed to understand the biological mechanism.
Treatment options for obesity including strength, form, and dosing details.
A recent article is only the latest in a series of studies drawing attention to the importance of diet in prostate cancer development.
The median proportion of obese patients was 18%, as observed over 22 RCTs.
The longer a woman is overweight, the higher her risk of several cancers.
[Gastrointestinal Cancer: Targets and Therapy] Obesity is now recognized as one of the foremost modifiable cancer risk factors.
Robotic surgery is safe and feasible for the surgical management of morbidly obese patients with endometrial cancer.
Risk for breast cancer among obese women may be up to 58 percent higher than for normal-weight postmenopausal women.
Certain treatments may increase a childhood cancer survivor's risk of obesity later in life.
Obesity takes a huge toll on health, and a new study finds that obese women have a 40 percent higher risk for cancer than thinner women.
Chemotherapy can be dosed based on body surface area or body weight, but some studies show up to 40% of obese patients receive lower doses.
For black women, obesity increases postmenopausal risk of breast cancer by 31 percent.
Researchers conducted what they say is the largest study of its kind to assess the link between BMI and cancer.
Changes in adipose tissue precede the development of cachexia symptoms, and suggest a treatment approach.
ASCO recommendation tasks oncologists with assisting obese patients with cancer in finding appropriate resources for weight management.
Most of the excess deaths attributed to heart disease, cancer, and diabetes.
Weight-loss surgery may do more than lower the risk of heart problems and improve type 2 diabetes in obese patients.
Changes to the colon that may lead to colorectal cancer appear to be caused by obesity, rather than diet, in mice.
Obese individuals have increased odds of having three or more polyps and tubular adenomas.
For the first time, researchers find a link between excess body weight and death from oral cancer.
Increased adiponectin concentration seen in all postmenopausal women at increased risk of breast cancer.
Central abdominal adiposity is associated with an increased risk of esophageal inflammation, metaplasia, and adenocarcinoma.
Obesity not only increases risk for diabetes and cardiovascular diseases; it can also be a risk factor for many types of cancer.
American Cancer Society stresses that stronger efforts to cut tobacco use and obesity and expand screening test use could prevent much of the suffering and deaths associated with cancer.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Genetic Counseling Recommended for Advanced Prostate Cancer
- BRCA1/Shieldin Double Mutations May Signal Resistance to PARP Inhibitors
- Higher-Dose Immunoglobulin Replacement Therapy in Chronic Lymphocytic Leukemia
- "Impressive" CNS Responses With Osimertinib Compared With Standard EGFR-TKIs in Patients With CNS Metastases at Baseline
- Study Zeroes in on Cause of Castration-Resistant Prostate Cancer
- Higher Doses of Image-Guided Neoadjuvant Radiation Therapy Found to Be Safe in Locally Advanced NSCLC: Study
- Supply Shortages of Bacillus Calmette-Guérin Found to Spur Drug Rationing in Non-Muscle-Invasive Bladder Cancer
- Study Analyzing Postmarketing Data on Breast Implant Safety Sparks FDA Response
- Epacadostat and Pembrolizumab Combo Active in Relapsed NSCLC
- PD-1 Inhibitor Cemiplimab Shows Antitumor Activity in Relapsed NSCLC